The contract wins span onshore, offshore and diversified critical infrastructure projects globally, underlining the company’s continued expansion following a strong 2025 ... .
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30) ... This CRc rate is comprised of a complete remission (CR) rate of 30% and complete remission with partial hematological recovery (CRh) of 10%.